Halozyme Therapeutics Total Assets 2006-2020 | HALO

Halozyme Therapeutics total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Halozyme Therapeutics Annual Total Assets
(Millions of US $)
2019 $566
2018 $440
2017 $520
2016 $262
2015 $182
2014 $166
2013 $102
2012 $135
2011 $66
2010 $91
2009 $77
2008 $77
2007 $103
2006 $46
2005 $21
Halozyme Therapeutics Quarterly Total Assets
(Millions of US $)
2020-06-30 $527
2020-03-31 $492
2019-12-31 $566
2019-09-30 $370
2019-06-30 $418
2019-03-31 $429
2018-12-31 $440
2018-09-30 $445
2018-06-30 $475
2018-03-31 $495
2017-12-31 $520
2017-09-30 $357
2017-06-30 $345
2017-03-31 $227
2016-12-31 $262
2016-09-30 $282
2016-06-30 $296
2016-03-31 $309
2015-12-31 $182
2015-09-30 $159
2015-06-30 $174
2015-03-31 $159
2014-12-31 $166
2014-09-30 $165
2014-06-30 $182
2014-03-31 $198
2013-12-31 $102
2013-09-30 $110
2013-06-30 $107
2013-03-31 $117
2012-12-31 $135
2012-09-30 $108
2012-06-30 $122
2012-03-31 $135
2011-12-31 $66
2011-09-30 $78
2011-06-30 $90
2011-03-31 $81
2010-12-31 $91
2010-09-30 $100
2010-06-30 $51
2010-03-31 $65
2009-12-31 $77
2009-09-30 $86
2009-06-30 $96
2009-03-31 $69
2008-12-31 $77
2008-09-30 $81
2008-06-30 $89
2008-03-31 $99
2007-12-31 $103
2007-09-30 $110
2007-06-30 $104
2007-03-31 $74
2006-12-31 $46
2006-09-30 $18
2006-06-30 $17
2006-03-31 $19
2005-12-31 $21
2005-09-30 $7
2005-06-30 $11
2005-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.644B $0.196B
Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.435B 15.47
Bristol Myers Squibb (BMY) United States $130.716B 10.06
CSL (CSLLY) Australia $92.739B 0.00
Gilead Sciences (GILD) United States $80.502B 11.59
Vertex Pharmaceuticals (VRTX) United States $68.763B 38.37
Regeneron Pharmaceuticals (REGN) United States $59.122B 22.61
Biogen (BIIB) United States $42.476B 7.27
Illumina (ILMN) United States $39.439B 45.86
Seattle Genetics (SGEN) United States $31.116B 0.00
Moderna (MRNA) United States $27.329B 0.00
Genmab (GMAB) Denmark $25.215B 15.93
BeiGene (BGNE) Cayman Islands $24.505B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.490B 10.20
Genmab (GNMSF) Denmark $23.747B 5.47
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.148B 0.00
Immunomedics (IMMU) United States $19.742B 0.00
Incyte (INCY) United States $18.675B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.277B 38.09
Alnylam Pharmaceuticals (ALNY) United States $15.183B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioNTech SE (BNTX) Germany $14.960B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.015B 101.68
ARGENX SE-ADR (ARGX) Netherlands $11.705B 0.00
QIAGEN (QGEN) Netherlands $11.415B 28.97
Sarepta Therapeutics (SRPT) United States $11.214B 0.00
Exact Sciences (EXAS) United States $11.039B 0.00
Guardant Health (GH) United States $10.606B 0.00
Bio-Techne Corp (TECH) United States $9.165B 62.88
Galapagos (GLPG) Belgium $9.113B 33.02
Exelixis (EXEL) United States $7.975B 29.00
SWEDISH ORP BIO (BIOVF) Sweden $7.814B 19.44
Repligen (RGEN) United States $7.447B 118.21
Ascendis Pharma (ASND) Denmark $7.435B 0.00
Mirati Therapeutics (MRTX) United States $7.222B 0.00
Novavax (NVAX) United States $6.750B 0.00
MyoKardia (MYOK) United States $6.697B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.515B 0.00
Acceleron Pharma (XLRN) United States $6.417B 0.00
Adaptive Biotechnologies (ADPT) United States $6.399B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.234B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.974B 185.07
Emergent Biosolutions (EBS) United States $5.292B 20.96
Ultragenyx Pharmaceutical (RARE) United States $4.874B 0.00
China Biologic Products (CBPO) China $4.367B 25.92
MorphoSys AG (MOR) Germany $4.315B 56.55
Blueprint Medicines (BPMC) United States $4.268B 0.00
Zai Lab (ZLAB) China $4.259B 0.00
Arena Pharmaceuticals (ARNA) United States $4.073B 0.00
Vir Biotechnology (VIR) United States $4.066B 0.00
NeoGenomics (NEO) United States $3.877B 1170.33
Denali Therapeutics (DNLI) United States $3.858B 0.00
Bluebird Bio (BLUE) United States $3.609B 0.00
Legend Biotech (LEGN) United States $3.554B 0.00
Reata Pharmaceuticals (RETA) United States $3.509B 0.00
Amicus Therapeutics (FOLD) United States $3.488B 0.00
Principia Biopharma (PRNB) United States $3.321B 0.00
Global Blood Therapeutics (GBT) United States $3.320B 0.00
Insmed (INSM) United States $3.312B 0.00
Fate Therapeutics (FATE) United States $3.218B 0.00
Twist Bioscience (TWST) United States $2.992B 0.00
Inovio Pharmaceuticals (INO) United States $2.963B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.951B 0.00
Alkermes (ALKS) Ireland $2.736B 57.33
Sorrento Therapeutics (SRNE) United States $2.361B 0.00
PHARMA MAR SA (PHMMF) Spain $2.290B 0.00
I-Mab (IMAB) China $2.129B 0.00
Mesoblast (MESO) Australia $2.038B 0.00
Intra-Cellular Therapies (ITCI) United States $2.025B 0.00
Editas Medicine (EDIT) United States $2.014B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Seres Therapeutics (MCRB) United States $2.003B 0.00
Zymeworks (ZYME) Canada $2.001B 0.00
Revance Therapeutics (RVNC) United States $1.911B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Eidos Therapeutics (EIDX) United States $1.836B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.796B 0.00
UniQure (QURE) Netherlands $1.721B 0.00
Amarin (AMRN) Ireland $1.546B 0.00
Beam Therapeutics (BEAM) United States $1.530B 0.00
Cytokineticsorporated (CYTK) United States $1.500B 0.00
Mersana Therapeutics (MRSN) United States $1.487B 0.00
Viela Bio (VIE) United States $1.476B 0.00
Sangamo Therapeutics (SGMO) United States $1.454B 0.00
Zealand Pharma (ZEAL) Denmark $1.449B 0.00
Ligand Pharmaceuticals (LGND) United States $1.447B 48.90
Dicerna Pharmaceuticals (DRNA) United States $1.386B 0.00
Coherus BioSciences (CHRS) United States $1.372B 8.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.326B 0.00
Intellia Therapeutics (NTLA) United States $1.307B 0.00
Epizyme (EPZM) United States $1.300B 0.00
Arcus Biosciences (RCUS) United States $1.244B 0.00
Compugen (CGEN) Israel $1.213B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.211B 0.00
NGM Biopharmaceuticals (NGM) United States $1.204B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.109B 0.00
Arvinas (ARVN) United States $1.071B 0.00
REGENXBIO (RGNX) United States $1.036B 0.00
Castle Biosciences (CSTL) United States $1.024B 0.00
Athenex (ATNX) United States $1.023B 0.00
Alcobra (ARCT) United States $0.993B 0.00
Alector (ALEC) United States $0.990B 0.00
Retrophin (RTRX) United States $0.955B 0.00
Myriad Genetics (MYGN) United States $0.940B 0.00
Adverum Biotechnologies (ADVM) United States $0.931B 0.00
Heska (HSKA) United States $0.916B 0.00
NantKwest (NK) United States $0.869B 0.00
Agenus (AGEN) United States $0.859B 0.00
Pliant Therapeutics (PLRX) United States $0.847B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.843B 0.00
Vericel (VCEL) United States $0.833B 0.00
Morphic Holding (MORF) United States $0.827B 0.00
Cellectis S.A (CLLS) France $0.825B 0.00
Frequency Therapeutics (FREQ) United States $0.817B 0.00
VBI Vaccines (VBIV) United States $0.788B 0.00
Protagonist Therapeutics (PTGX) United States $0.776B 0.00
Kadmon Holdings (KDMN) United States $0.732B 0.00
Intrexon (PGEN) United States $0.724B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
MiMedx (MDXG) United States $0.700B 0.00
Northwest Biotherapeutics (NWBO) United States $0.699B 0.00
Codexis (CDXS) United States $0.689B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
AC Immune SA (ACIU) Switzerland $0.638B 0.00
Clovis Oncology (CLVS) United States $0.624B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.605B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.584B 0.00
Geron (GERN) United States $0.582B 0.00
Albireo Pharma (ALBO) United States $0.564B 0.00
Dynavax Technologies (DVAX) United States $0.556B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.550B 0.00
WAVE Life Sciences (WVE) Singapore $0.549B 0.00
Scholar Rock Holding (SRRK) United States $0.538B 0.00
Cel-Sci (CVM) United States $0.520B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.514B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.510B 4.47
IVERIC Bio (ISEE) United States $0.508B 0.00
Kala Pharmaceuticals (KALA) United States $0.501B 0.00
Celldex Therapeutics (CLDX) United States $0.490B 0.00
Anika Therapeutics (ANIK) United States $0.488B 21.35
Orchard Therapeutics (ORTX) United Kingdom $0.476B 0.00
MeiraGTx Holdings (MGTX) United States $0.475B 0.00
Forte Biosciences (FBRX) United States $0.471B 0.00
Cue Biopharma (CUE) United States $0.470B 0.00
Syros Pharmaceuticals (SYRS) United States $0.463B 0.00
MannKind (MNKD) United States $0.458B 0.00
Starpharma Holdings (SPHRY) Australia $0.440B 0.00
Pfenex (PFNX) United States $0.435B 0.00
AnaptysBio (ANAB) United States $0.432B 0.00
IBio (IBIO) United States $0.424B 0.00
Avid Bioservices (CDMO) United States $0.422B 0.00
UROGEN PHARMA (URGN) United States $0.421B 0.00
Amryt Pharma (AMYT) United Kingdom $0.416B 0.00
Fortress Biotech (FBIO) United States $0.411B 0.00
Athersys (ATHX) United States $0.409B 0.00
Prothena (PRTA) Ireland $0.408B 0.00
BioDelivery Sciences (BDSI) United States $0.395B 27.93
Sutro Biopharma (STRO) United States $0.394B 0.00
Puma Biotechnology (PBYI) United States $0.393B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.392B 0.00
Kamada (KMDA) Israel $0.388B 18.53
Bicycle Therapeutics (BCYC) United Kingdom $0.368B 0.00
PDL BioPharma (PDLI) United States $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.359B 0.00
Trevena (TRVN) United States $0.354B 0.00
ANI Pharmaceuticals (ANIP) United States $0.348B 8.21
Merus (MRUS) Netherlands $0.345B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.337B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.322B 0.00
CytomX Therapeutics (CTMX) United States $0.321B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Innate Pharma S.A (IPHA) France $0.305B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.289B 0.00
OSMOTICA PHARM (OSMT) United States $0.279B 0.00
Affimed (AFMD) Germany $0.278B 0.00
Selecta Biosciences (SELB) United States $0.272B 0.00
Cardiff Oncology (CRDF) United States $0.269B 0.00
Cyclerion Therapeutics (CYCN) United States $0.266B 0.00
Prometic Life Sciences (LMNL) Canada $0.260B 0.00
NextCure (NXTC) United States $0.259B 0.00
ChromaDex (CDXC) United States $0.257B 0.00
Arbutus Biopharma (ABUS) United States $0.251B 0.00
Pluristem Therapeutics (PSTI) Israel $0.251B 0.00
TELA Bio (TELA) United States $0.229B 0.00
Verastem (VSTM) United States $0.222B 0.00
HOOKIPA Pharma (HOOK) United States $0.217B 0.00
Dyadic (DYAI) United States $0.209B 0.00
Liquidia Technologies (LQDA) United States $0.208B 0.00
DBV Technologies S.A (DBVT) France $0.207B 0.00
Spero Therapeutics (SPRO) United States $0.206B 0.00
Aduro Biotech (ADRO) United States $0.205B 0.00
XOMA (XOMA) United States $0.204B 0.00
Checkpoint Therapeutics (CKPT) United States $0.201B 0.00
Kindred Biosciences (KIN) United States $0.197B 0.00
ADMA Biologics Inc (ADMA) United States $0.195B 0.00
Cerecor (CERC) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Biofrontera AG (BFRA) Germany $0.186B 0.00
Eton Pharmaceuticals (ETON) United States $0.183B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
CorMedix Inc (CRMD) United States $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.175B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.167B 7.80
Exicure (XCUR) United States $0.167B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
SESEN BIO, INC (SESN) United States $0.163B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.162B 0.00
GENFIT S.A (GNFT) France $0.161B 0.00
Aptinyx (APTX) United States $0.157B 0.00
Aytu Bioscience (AYTU) United States $0.157B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.156B 0.00
AquaBounty Technologies (AQB) United States $0.156B 0.00
Nicox SA (NICXF) France $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.146B 0.00
VolitionRX (VNRX) United States $0.146B 0.00
Bellus Health (BLU) Canada $0.142B 0.00
Five Prime Therapeutics (FPRX) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
Cidara Therapeutics (CDTX) United States $0.132B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.122B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
Protalix BioTherapeutics (PLX) Israel $0.118B 0.00
Strongbridge Biopharma (SBBP) United States $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.115B 0.00
Palatin Technologies (PTN) United States $0.115B 2.94
Gritstone Oncology (GRTS) United States $0.114B 0.00
Vaccinex (VCNX) United States $0.110B 0.00
Orgenesis (ORGS) United States $0.109B 5.56
Unum Therapeutics (UMRX) United States $0.109B 0.00
Enzo Biochem (ENZ) United States $0.109B 0.00
Antibe Therapeutics (ATBPF) Canada $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
ARAVIVE, INC (ARAV) United States $0.092B 0.00
Oncobiologics (OTLK) United States $0.091B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Idera Pharmaceuticals (IDRA) United States $0.090B 0.00
Bionano Genomics (BNGO) United States $0.088B 0.00
Evogene (EVGN) Israel $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Synlogic (SYBX) United States $0.074B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.072B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.068B 0.00
TRACON Pharmaceuticals (TCON) United States $0.068B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.064B 0.00
AmpliPhi Biosciences (ARMP) United States $0.063B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.059B 0.00
Soligenix (SNGX) United States $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.058B 0.00
Appili Therapeutics (APLIF) Canada $0.056B 0.00
AnPac Bio-Medical Science (ANPC) China $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Cocrystal Pharma (COCP) United States $0.051B 0.00
Stealth BioTherapeutics (MITO) United States $0.050B 72.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
Genetic Technologies (GENE) Australia $0.049B 0.00
CollPlant Holdings (CLGN) Israel $0.049B 0.00
Novogen (KZIA) Australia $0.048B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.048B 0.00
Signal Genetics (MGEN) United States $0.047B 0.00
Organovo Holdings (ONVO) United States $0.045B 0.00
IMMURON (IMRN) Australia $0.045B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
ATyr Pharma (LIFE) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Prana Biotechnology (ATHE) Australia $0.034B 0.00
BioCardia (BCDA) United States $0.032B 0.00
OvaScience (MLND) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
Acorda Therapeutics (ACOR) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cesca Therapeutics (THMO) United States $0.022B 0.00
Spherix (AIKI) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00